XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Jun. 01, 2021
May 31, 2021
Stock-Based Compensation              
Options outstanding 1,657,342   1,657,342   1,489,748    
Options granted     348,294        
Weighted average exercise price     $ 15.90        
Stock-based compensation expense $ 2,356,011 $ 785,942 $ 7,694,716 $ 817,911      
Options, vested and exercisable 1,284,343   1,284,343   1,105,568    
General and administrative              
Stock-Based Compensation              
Stock-based compensation expense $ 1,627,820 449,714 $ 5,053,502 481,683      
Research and development              
Stock-Based Compensation              
Stock-based compensation expense 728,191 $ 336,228 $ 2,641,214 $ 336,228      
Stock Options              
Stock-Based Compensation              
Weighted average grant date fair value     $ 13.24        
Exercise of stock options, shares     70,101 159,813      
Stock Options | Weighted average              
Stock-Based Compensation              
Expected term (in years)     5 years 10 months 24 days        
Risk-free interest rate     2.24%        
Expected volatility     112.00%        
Dividend yield (as a percent)     0.00%        
Stock Options | General and administrative              
Stock-Based Compensation              
Stock option modification expense $ 1,219,572            
Stock Options | Performance-based vesting              
Stock-Based Compensation              
Options granted     20,000        
Stock-based compensation expense     $ 0        
Stock Options | Service-based vesting, quarterly installments              
Stock-Based Compensation              
Vesting period     2 years        
Term of award (in years)     10 years        
Previous Plans              
Stock-Based Compensation              
Shares available for future grants 0   0        
2019 Plan              
Stock-Based Compensation              
Shares authorized           2,000,000 1,000,000
Shares available for future grants 392,874   392,874